This observation is counterintuitive given the strong evidence that both in patients and in causative mutation-driven animal models, myelofibrosis is sustained by abnormal GATA1 hypomorphic megakaryocytes (Vannucchi et al., 2005; Gilles et al., 2017). Here, GATA1 is linked to myelofibrosis.